These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 3299819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of claudication with dipyridamole and aspirin.
    Libretti A, Catalano M.
    Int J Clin Pharmacol Res; 1986; 6(1):59-60. PubMed ID: 3514494
    [Abstract] [Full Text] [Related]

  • 3. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 4. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A, McCans J, Willan AR, Ford PM.
    J Rheumatol; 1985 Aug 15; 12(4):724-7. PubMed ID: 3903157
    [Abstract] [Full Text] [Related]

  • 5. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
    Rodeheffer RJ, Rommer JA, Wigley F, Smith CR.
    N Engl J Med; 1983 Apr 14; 308(15):880-3. PubMed ID: 6339921
    [No Abstract] [Full Text] [Related]

  • 6. Aspirin and dipyridamole ineffective in treatment of necrobiosis lipoidica.
    Statham BN, Finlay AY, Marks R.
    N Engl J Med; 1980 Dec 11; 303(24):1419. PubMed ID: 7001236
    [No Abstract] [Full Text] [Related]

  • 7. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A, Amor B, Menkès CJ.
    Rev Rhum Mal Osteoartic; 1987 Jun 11; 54(6):487-90. PubMed ID: 3303287
    [Abstract] [Full Text] [Related]

  • 8. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J, Kraus A, González-Amaro R, Alarcón-Segovia D.
    J Rheumatol; 1984 Jun 11; 11(3):362-4. PubMed ID: 6376801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. I. General protocol. From the DAMAD Study Group (author's transl)].
    Diabete Metab; 1982 Jun 11; 8(2):91-6. PubMed ID: 7049782
    [Abstract] [Full Text] [Related]

  • 12. A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
    Statham B, Finlay AY, Marks R.
    Acta Derm Venereol; 1981 Jun 11; 61(3):270-1. PubMed ID: 6167117
    [Abstract] [Full Text] [Related]

  • 13. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA, Mellinger S, Kohler J, Dorsey JK, Furst DE.
    J Rheumatol; 1987 Aug 11; 14(4):745-50. PubMed ID: 3312603
    [Abstract] [Full Text] [Related]

  • 14. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 Aug 11; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 15. [Dipyridamole plus acetylsalicylic acid--who is to be trusted?].
    Almdal TP, Eldrup E, Godtfredsen J, Kofoed-Enevoldsen A.
    Ugeskr Laeger; 1999 Aug 23; 161(34):4771-2. PubMed ID: 10500471
    [No Abstract] [Full Text] [Related]

  • 16. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Surwit RS, Gilgor RS, Allen LM, Duvic M.
    Arch Dermatol; 1984 Mar 23; 120(3):329-31. PubMed ID: 6367665
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A double-blind clinical trial of a topical preparation with a base of biochemical precursors of glucosaminoglycan (GAG) in patients suffering from Raynaud's disease].
    Signorini GP.
    Boll Chim Farm; 1986 Oct 23; 125(10):103S-110S. PubMed ID: 3551995
    [No Abstract] [Full Text] [Related]

  • 20. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R, Shariat K, von Wilmowsky H, Böhm M.
    Circulation; 2005 Nov 08; 112(19):2980-5. PubMed ID: 16275885
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.